Remove BioTech Remove Code Remove Efficiency
article thumbnail

The Financialization of Disruptive Technology

The Agile Manager

A recent FT Lex article on biotech investing drives the point home: "A 20-year study found only one-fifth of exits were profitable. The formula was to exploit the adaptability of software and expedite its application: get new code changes deployed every month, every day, every hour when possible. Picking winners is hard.